Carregant...
Use of analgesics in France, following dextropropoxyphene withdrawal
BACKGROUND: In 2009, the European Medicines Agency recommended withdrawal of dextropropoxyphene (DXP); in March 2011 it was withdrawn from the market in France. Up until that time the combination dextropropoxyphene-paracetamol (DXP/PC) was widely used for analgesia. At withdrawal, French regulators...
Guardat en:
| Publicat a: | BMC Health Serv Res |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5880096/ https://ncbi.nlm.nih.gov/pubmed/29609613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-018-3058-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|